Albert S. Baldwin, Ph.D.

Albert S. Baldwin, Ph.D.

Associate Director of the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Dr. Baldwin is Kenan Distinguished Professor and Associate Director of the Lineberger Comprehensive Cancer Center at the University of North Carolina School of Medicine.  His research focuses on understanding the involvement of the NF-kappaB transcription factor pathway in promoting oncogenesis and driving cancer therapy resistance.  He is the author of over 150 peer-reviewed manuscripts and is the founder of TheraLogics, a company directed at inhibiting the NF-kappaB pathway in a variety of cancers and human diseases.

 

Share |

Join us in our fight for a cure!